Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Barriers and Solutions to Expanding PrEP Uptake: A Nursing Perspective
  • CE

Credits Available
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: June 14, 2022 Expiration: June 13, 2023
Start Activity
Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare
Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
person default
Christopher Fox, MSN, RN, ANP-BC, AAHIVS

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply a thorough understanding of available clinical data, practice guidelines, and patient preferences to ensure that long-acting ART is considered as a treatment strategy for patients for whom it may be appropriate
  • Integrate strategies to administer long-acting ART, support patient adherence to dosing visits, and monitor its efficacy and safety in clinical settings
  • Appraise the role of long-acting PrEP in HIV prevention strategies based on considerations including efficacy, safety, and patient preferences

Information on this Educational Activity

Program Director

Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Joseph J. Eron, Jr., MD, has disclosed that he has received consultant/advisor/speaker fees from Gilead Sciences, Janssen, Merck, and ViiV Healthcare and funds for research support from Gilead Sciences, Janssen, and ViiV Healthcare.
Jeffrey Kwong, DNP, MPH, FAANP, FAAN

Professor
Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Jeffrey Kwong, DNP, MPH, FAANP, FAAN, has no relevant conflicts of interest to report.
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP, has disclosed that she has received consultant/advisor/speaker fees from Gilead Sciences, Janssen, Merck, Theratechnologies, and ViiV Healthcare.

Faculty

Christopher Fox, MSN, RN, ANP-BC, AAHIVS

Instructor
Division of General Internal Medicine and Geriatrics
Oregon Health & Science University
Nurse Practitioner
Division of General Internal Medicine and Geriatrics
OHSU HIV Clinic
Portland, Oregon

Christopher Fox, MSN, RN, ANP-BC, AAHIVS, has no relevant conflicts of interest to report.

Staff

Jessica Adams, PharmD, BCPS, AAHIVP

Scientific Director

Jessica Adams, PharmD, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schultz, PhD, has no relevant conflicts of interest to report.

Target Audience

This program is intended for registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Goal

The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.

Nursing Continuing Professional Development

Accreditation Statement

The Association of Nurses in AIDS Care (ANAC) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

Upon full participation in this activity and completion of an evaluation, participants will be awarded 1.0 nursing contact hour including 1.0 hour of pharmacotherapeutics content.

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-154-H02-P.

Type of Activity: Application

Upon successfully completing the post-test with a score of 50% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 14, 2022, through June 13, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 50% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Barriers and Solutions to Expanding PrEP Uptake: A Nursing Perspective
  • CE

Source: Contemporary HIV Treatment and Prevention 2022
Loading...
Listen to expert faculty as they discuss inequities in PrEP uptake in key populations, structural barriers to PrEP adoption, and solutions for expanding PrEP use.
Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
person default
Christopher Fox, MSN, RN, ANP-BC, AAHIVS
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: June 14, 2022 Expiration: June 13, 2023

Related Content

Expert summaries of the HIV care cascade and strategies and interventions to improve linkage to care for PWH, from Clinical Care Options (CCO)

Babafemi Taiwo, MBBS
Program Director Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD Released: August 3, 2022

Expert summaries of barriers to HIV diagnosis, consequences of late HIV diagnosis, strategies to improve HIV testing, from Clinical Care Options (CCO)

Babafemi Taiwo, MBBS
Program Director Released: August 3, 2022

Expert insights on new, emerging, and potential future long-acting antiretroviral agents for HIV treatment and prevention, from Clinical Care Options (CCO)

Babafemi Taiwo, MBBS
Program Director person default Yvonne Gilleece, MB BCh, BAO Cristina Mussini, MD Darrell H. S. Tan, MD, FRCPC, PhD Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Registered Nurses: 2.0 Nursing contact hours Pharmacists: 2.0 contact hours (0.2 CEUs) Released: July 29, 2022 Expired: July 28, 2023
Introduction
Current Landscape of Long-Acting ART for Treatment of HIV
Current Landscape of Long-Acting Options for Prevention of HIV
Incorporating Long-Acting ART for Treatment and Prevention Into Clinical Practice: Adherence
Incorporating Long-Acting ART for Treatment and Prevention Into Clinical Practice: System Demands for Successful Implementation
Panel Discussion: Strategies to Maximize Uptake
Emerging Long-Acting ART Regimens for HIV Treatment and Prevention
Panel Discussion: Long-Acting ART in the HIV Armamentarium—What Does the Future Hold?
Questions and Answers
Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings